https://globalcommissionforpostpandemicpolicy.org/wp-content/uploads/2021/06/mika-baumeister-Tz1k07Jl2no-unsplash.jpg 1000 1500 GCPPP Staff https://globalcommissionforpostpandemicpolicy.org/wp-content/uploads/2020/11/logo-2-web.png GCPPP Staff2021-06-24 11:39:532021-06-24 11:39:53The European Union’s vaccine-acquisition strategy
The European Union’s vaccine-acquisition strategy/in Analysis /by GCPPP Staff
When pharmaceutical companies began distributing COVID-19 vaccines in late 2020 and early 2021, the European Union fell immediately behind the United Kingdom and United States in the number of doses administered. It faced shortages while, at the same time, allowing a substantial share of the vaccines it was receiving to be exported. This slow initial roll-out – which happened just as another wave of the pandemic was hitting many EU member states – has been extremely costly in human and economic terms and has battered the reputation of the European Commission.
https://globalcommissionforpostpandemicpolicy.org/wp-content/uploads/2021/06/fusion-medical-animation-rnr8D3FNUNY-unsplash_1500x1000-min.jpg 1000 1500 Luke Lythgoe https://globalcommissionforpostpandemicpolicy.org/wp-content/uploads/2020/11/logo-2-web.png Luke Lythgoe2021-06-01 13:30:582021-06-25 10:40:46Variants
Variants/in Analysis /by Luke Lythgoe
Cite our materials
Using our materials? Please cite the source.
You can get in touch by email or send us a direct message on Twitter.